{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:02:39Z","timestamp":1776052959515,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamadermatol.2021.4302","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T15:34:01Z","timestamp":1635348841000},"page":"1508","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics and Outcomes of Eosinophilic Fasciitis\u2013Associated Monoclonal Gammopathy"],"prefix":"10.1001","volume":"157","author":[{"given":"Daniel R.","family":"Mazori","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bina","family":"Kassamali","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, University of California Irvine School of Medicine, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avery H.","family":"LaChance","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Sperling","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts"},{"name":"Division of Hematology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"dld210021r1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamadermatol.2015.3648","article-title":"Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers.","volume":"152","author":"Wright","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dld210021r2","first-page":"688","article-title":"Colitis and pericarditis in a patient with eosinophilic fasciitis. a contribution to the multisystem nature of eosinophilic fasciitis.","volume":"16","author":"Naschitz","year":"1989","journal-title":"J Rheumatol"},{"issue":"5","key":"dld210021r3","first-page":"574","article-title":"Eosinophilic fasciitis associated with a monoclonal immunoglobulin.","volume":"12","author":"Goldner","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"dld210021r4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/ard.61.12.1111","article-title":"Eosinophilic fasciitis with multiple myeloma: a new haematological association.","volume":"61","author":"Khanna","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"dld210021r5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"13","key":"dld210021r6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2785541\/jamadermatology_mazori_2021_ld_210021_1639533863.9032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T16:09:29Z","timestamp":1639584569000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2785541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4302","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}